Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states.
Laboratory-based coronary heart disease risk assessment classically involves measurement of lipids and lipoproteins. In this review, information is provided on the methods commonly used in laboratories for the diagnosis of hyperlipidemia, including aspects of precision and accuracy. The latter, when fulfilled, allows the use of uniform reference values. Special attention is paid to the risk estimation using apolipoprotein B and lipoprotein(a) measurement. The overall aim of this review is to simplify the laboratory-based risk estimation for coronary heart disease and to provide help in interpreting the results for effective prevention and treatment of this complex disease.
Demacker
Pierre N M
PN
Laboratory of General Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands. p.demacker@aig.umcn.nl
D019411:Clinical Laboratory Techniques; D003327:Coronary Disease / Q000097:blood / Q000175:diagnosis; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000145:classification* / Q000175:diagnosis; D006953:Hyperlipoproteinemia Type IV / Q000097:blood* / Q000145:classification* / Q000175:diagnosis; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D018570:Risk Assessment
D008055:Lipids; D008074:Lipoproteins